Pharmacokinetic determinants of carbapenem therapy in neonates and children
Author:
- 2 August 1996
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 15 (8) , 733-737
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- MeropenemDrugs, 1995
- Use of fluoroquinolones in pediatricsThe Pediatric Infectious Disease Journal, 1995
- Imipenem/CilastatinDrugs, 1992
- Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1992
- Fluoroquinolone Antimicrobial AgentsNew England Journal of Medicine, 1991
- Interactions in vitro between agents used to treat melioidosisJournal of Antimicrobial Chemotherapy, 1989
- AztreonamDrugs, 1986
- Carbapenems, a new class of beta-lactam antibioticsThe American Journal of Medicine, 1985
- Pharmacokinetics of imipenem in healthy volunteersJournal of Antimicrobial Chemotherapy, 1983
- Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-IAntimicrobial Agents and Chemotherapy, 1982